SCHEMBL22698795

SCHEMBL22698795

CN1C(=O)[C@@H]2[C@H](C1=O)[C@H]1C=C[C@@H]2O1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 2/20 0.52
ALDH1A1 P00352 15/20 0.44
HPGD P15428 3/20 0.44
MAPT P10636 2/20 0.44
HTT P42858 2/20 0.44
HSD17B10 Q99714 2/20 0.44
CACNA1B Q00975 1/20 0.44
APBA1 Q02410 1/20 0.44
CYP3A4 P08684 1/20 0.39
PKM P14618 4/20 0.38
NPC1 O15118 1/20 0.38
POLB P06746 1/20 0.37
CYP1A2 P05177 1/20 0.36
CYP2C19 P33261 1/20 0.36
TDP1 Q9NUW8 1/20 0.35
OPRM1 P35372 1/20 0.33
OPRD1 P41143 1/20 0.33
OPRK1 P41145 1/20 0.33
USP2 O75604 1/20 0.33
ALOX15 P16050 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13239561 1.00 ATM (0.52) ATMALDH1A1HPGDMAPTHTT
SCHEMBL14536984 1.00 ATM (0.52) ATMALDH1A1HPGDMAPTHTT
SCHEMBL84627 1.00 ATM (0.52) ATMALDH1A1HPGDMAPTHTT
SCHEMBL13239540 1.00 ATM (0.52) ATMALDH1A1HPGDMAPTHTT
SCHEMBL14527535 1.00 ATM (0.52) ATMALDH1A1HPGDMAPTHTT
SCHEMBL19303302 0.86 ATM (0.44) ATMALDH1A1HPGDMAPTHTT
SCHEMBL14378375 0.77 ALDH1A1 (0.46) ATMALDH1A1HPGDMAPTHTT
SCHEMBL14378694 0.77 ALDH1A1 (0.46) ATMALDH1A1HPGDMAPTHTT
SCHEMBL10126356 0.77 ALDH1A1 (0.46) ATMALDH1A1HPGDMAPTHTT
SCHEMBL18912900 0.76 ATM (0.52) ATMALDH1A1HPGDMAPTHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210330693-A1 HEPARANASE INHIBITORS AND THEIR USE AS ANTI-CANCER COMPOUNDS WAYNE STATE UNIVERSITY (US) 2021-10-28 US disclosed
US-20210317143-A9 BORONIC ESTER PRODRUGS AND USES THEREOF MASSACHUSETTS INSTITUTE OF TECHNOLOGY 2021-10-14 US disclosed
WO-2020236253-A1 BORONIC ESTER PRODRUGS AND USES THEREOF MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2020-11-26 WO disclosed
US-20200369685-A1 BORONIC ESTER PRODRUGS AND USES THEREOF MASSACHUSETTS INST TECHNOLOGY (US) 2020-11-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200369685-A1 BORONIC ESTER PRODRUGS AND USES THEREOF BRCA1, BTD, BCHE ATM 4226/4885ALDH1A1 731/4885HPGD 162/4885
US-20210330693-A1 HEPARANASE INHIBITORS AND THEIR USE AS ANTI-CANCER COMPOUNDS HPSE, ENGASE, FUCA1 ATM 4352/4885ALDH1A1 2582/4885HPGD 1151/4885
US-20210317143-A9 BORONIC ESTER PRODRUGS AND USES THEREOF BRCA1, BTD, BCHE ATM 4226/4885ALDH1A1 731/4885HPGD 162/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.